Stay updated on ARO-APOC3 in FCS Clinical Trial
Sign up to get notified when there's something new on the ARO-APOC3 in FCS Clinical Trial page.

Latest updates to the ARO-APOC3 in FCS Clinical Trial page
- Check6 days agoChange DetectedAdded a Show glossary option and updated metadata to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0. Capitalization and wording changes were made to labels such as No FEAR Act data.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no user-visible content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check42 days agoChange DetectedAdded multiple study locations across the US and international sites (e.g., Florida, Georgia, Indiana, Maryland, Missouri, New York, Texas, Virginia, New South Wales, Victoria, Ontario, Quebec, Cedez 05, Mexico DF, Morelos, Kayseri) and introduced a 'Results Submitted' status. Several existing locations were removed, and the page version updated to v3.3.3.SummaryDifference1%

- Check64 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page; no study content or core details were affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange DetectedPublications section now includes a note that items are auto-filled from PubMed and may not all be about the study, and the page revision label was updated to v3.3.1. This is a metadata/update and does not change study details or eligibility criteria.SummaryDifference0.1%

- Check78 days agoChange DetectedRemoved the government funding lapse notice from the page, removing a site-wide operating-status message. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to ARO-APOC3 in FCS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARO-APOC3 in FCS Clinical Trial page.